KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthpeak Properties (DOC) Cost of Revenue (2017 - 2025)

Healthpeak Properties (DOC) has disclosed Cost of Revenue for 9 consecutive years, with $291.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 4.15% to $291.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 billion, a 9.39% increase, with the full-year FY2024 number at $1.1 billion, up 19.16% from a year prior.
  • Cost of Revenue was $291.9 million for Q3 2025 at Healthpeak Properties, up from $276.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $291.9 million in Q3 2025 to a low of $181.8 million in Q1 2021.
  • A 5-year average of $234.4 million and a median of $223.1 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: tumbled 39.8% in 2021, then rose 23.45% in 2024.
  • Healthpeak Properties' Cost of Revenue stood at $199.2 million in 2021, then rose by 10.66% to $220.5 million in 2022, then rose by 1.77% to $224.4 million in 2023, then rose by 23.45% to $277.0 million in 2024, then rose by 5.38% to $291.9 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Cost of Revenue are $291.9 million (Q3 2025), $276.2 million (Q2 2025), and $273.1 million (Q1 2025).